These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
486 related items for PubMed ID: 26960584
1. Effect of Dual Therapy with Botulinum Toxin A Injection and Electromyography-controlled Functional Electrical Stimulation on Active Function in the Spastic Paretic Hand. Tsuchiya M, Morita A, Hara Y. J Nippon Med Sch; 2016; 83(1):15-23. PubMed ID: 26960584 [Abstract] [Full Text] [Related]
3. Changes in movement characteristics of the spastic upper extremity after botulinum toxin injection. Hurvitz EA, Conti GE, Brown SH. Arch Phys Med Rehabil; 2003 Mar; 84(3):444-54. PubMed ID: 12638115 [Abstract] [Full Text] [Related]
6. [Effects of botulinum toxin guided by electric stimulation on spasticity in ankle plantar flexor of children with cerebral palsy: a randomized trial]. Xu KS, Yan TB, Mai JN. Zhonghua Er Ke Za Zhi; 2006 Dec; 44(12):913-7. PubMed ID: 17254459 [Abstract] [Full Text] [Related]
7. Local muscle injection of botulinum toxin type a synergistically improves the beneficial effects of repetitive transcranial magnetic stimulation and intensive occupational therapy in post-stroke patients with spastic upper limb hemiparesis. Yamada N, Kakuda W, Kondo T, Mitani S, Shimizu M, Abo M. Eur Neurol; 2014 Dec; 72(5-6):290-8. PubMed ID: 25323412 [Abstract] [Full Text] [Related]
8. The effects of electromyography-controlled functional electrical stimulation on upper extremity function and cortical perfusion in stroke patients. Hara Y, Obayashi S, Tsujiuchi K, Muraoka Y. Clin Neurophysiol; 2013 Oct; 124(10):2008-15. PubMed ID: 23706813 [Abstract] [Full Text] [Related]
13. Time course analysis of the effects of botulinum toxin type a on elbow spasticity based on biomechanic and electromyographic parameters. Lee HM, Chen JJ, Wu YN, Wang YL, Huang SC, Piotrkiewicz M. Arch Phys Med Rehabil; 2008 Apr; 89(4):692-9. PubMed ID: 18374000 [Abstract] [Full Text] [Related]
15. A preliminary assessment of the benefits of the addition of botulinum toxin a to a conventional therapy program on the function of people with longstanding stroke. Meythaler JM, Vogtle L, Brunner RC. Arch Phys Med Rehabil; 2009 Sep; 90(9):1453-61. PubMed ID: 19735771 [Abstract] [Full Text] [Related]
16. Botulinum toxin type A for upper limb spasticity following stroke: an open-label study with individualised, flexible injection regimens. Slawek J, Bogucki A, Reclawowicz D. Neurol Sci; 2005 Apr; 26(1):32-9. PubMed ID: 15877185 [Abstract] [Full Text] [Related]
17. Botulinum toxin-a in children with congenital spastic hemiplegia does not improve upper extremity motor-related function over rehabilitation alone: a randomized controlled trial. Rameckers EA, Speth LA, Duysens J, Vles JS, Smits-Engelsman BC. Neurorehabil Neural Repair; 2009 Apr; 23(3):218-25. PubMed ID: 19106252 [Abstract] [Full Text] [Related]
19. Safety and efficacy of incobotulinum toxin type A (NT 201-Xeomin) for the treatment of post-stroke lower limb spasticity: a prospective open-label study. Santamato A, Micello MF, Panza F, Fortunato F, Pilotto A, Giustini A, Testa A, Fiore P, Ranieri M, Spidalieri R. Eur J Phys Rehabil Med; 2013 Aug; 49(4):483-9. PubMed ID: 23480980 [Abstract] [Full Text] [Related]
20. Use of surface EMG for evaluation of upper limb spasticity during botulinum toxin therapy in stroke patients. Albani G, Cimolin V, Galli M, Vimercati S, Bar D, Campanelli L, Gandolfi R, Lombardi R, Mauro A. Funct Neurol; 2010 Aug; 25(2):103-7. PubMed ID: 20923608 [Abstract] [Full Text] [Related] Page: [Next] [New Search]